Calcitonin and carcinoembryonic antigen levels affected the prognosis of patients with MTC combined with PTC to some extent, with calcitonin being more sensitive than carcinoembryonic antigen. The gene discussed is CEACAM5; the disease is medullary thyroid gland carcinoma.